ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Pyzchiva 130 mg, Konzentrat zur Herstellung einer Infusionslösung - 
69985001 Samsung Bioepis CH GmbH
Pyzchiva 130 mg, Konzentrat zur Herstellung einer Infusionslösung21.03.2025
  21.03.2025
Ustekinumab (L04AC05) 
WHO-DDD20.03.2030
 
07.15. 
B  
No 
IP 
PR  
k.A.PR
  
7680699850013Biotechnologika
  
Composition
ustekinumabum 130 mg, histidinum, histidini hydrochloridum monohydricum, methioninum, dinatrii edetas, polysorbatum 80, saccharum, aqua ad iniectabile q.s. ad solutionem pro 26 ml corresp., natrium 0.066 mg.
Packungsbestandteile
Concentrate for infusion
 
 
Active AgentDose
Ustekinumabum130mg / 26ml
 
Inactive agents
Dinatrii Edetas
Histidin Hydrochloride Monohydrate
Histidine
Methionine
Polysorbatum 80
Saccharum
Source
Data was imported : 04.04.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home